RPMGX
Price
$109.07
Change
-$0.77 (-0.70%)
Updated
Sep 20 closing price
RPTTX
Price
$45.87
Change
-$0.05 (-0.11%)
Updated
Sep 20 closing price
Ad is loading...

RPMGX vs RPTTX

Header iconRPMGX vs RPTTX Comparison
Open Charts RPMGX vs RPTTXBanner chart's image
T. Rowe Price Mid-Cap Growth
Price$109.07
Change-$0.77 (-0.70%)
VolumeN/A
CapitalizationN/A
T. Rowe Price Diversified Mid Cap Gr I
Price$45.87
Change-$0.05 (-0.11%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
RPMGX vs RPTTX Comparison Chart
Loading...
VS
RPMGX vs. RPTTX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RPMGX is a StrongBuy and RPTTX is a Buy.

FUNDAMENTALS
Fundamentals
RPMGX has more cash in the bank: 31.4B vs. RPTTX (2.46B). RPMGX pays higher dividends than RPTTX: RPMGX (0.05) vs RPTTX (0.04). RPMGX was incepted earlier than RPTTX: RPMGX (32 years) vs RPTTX (7 years). RPTTX is a more actively managed with annual turnover of: 49.70 vs. RPMGX (21.70). RPMGX has a lower initial minimum investment than RPTTX: RPMGX (2500) vs RPTTX (500000). RPTTX annual gain was more profitable for investors over the last year : 20.90 vs. RPMGX (14.65). RPTTX return over 5 years is better than : 31.70 vs. RPMGX (14.51).
RPMGXRPTTXRPMGX / RPTTX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence32 years7 years-
Gain YTD9.02614.56062%
Front LoadN/AN/A-
Min. Initial Investment25005000001%
Min. Initial Investment IRAN/AN/A-
Net Assets31.4B2.46B1,274%
Annual Yield % from dividends0.050.04125%
Returns for 1 year14.6520.9070%
Returns for 3 years-13.81-11.64119%
Returns for 5 years14.5131.7046%
Returns for 10 years43.29N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CEAD6.90-0.10
-1.43%
CEA Industries
ELF112.91-1.68
-1.47%
elf Beauty
WAFD35.21-1.20
-3.30%
WaFd
PKST15.04-0.67
-4.26%
Peakstone Realty Trust
CHRS1.02-0.11
-9.73%
Coherus BioSciences